FRIEDMAN PAUL A sold MDGL
August 13, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 3,152 shares of Madrigal Pharmaceuticals, Inc. at $366.22 per share, a transaction worth $1.15M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,152
Price
$366.22
Total value
$1.15M
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 13, 2025
Shares owned after296,947
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.89 to $366.88, inclusive.